Photoswitchable Heparinase III for Enzymatic Preparation of Low Molecular Weight Heparin
Authors:
- 19 December 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 20 (1) , 48-51
Abstract
A photocontrollable biocatalyst was rationally designed by site-specifically linking a photoswitchable azobenzene derivative to the only cysteine residue in heparinase III mutant (K130C). Upon photoswitch, the enzymatic degradation of heparin could be artificially controlled to produce low molecular weight heparin with more uniform molecular weight and an increase in anticoagulant activity.Keywords
Funding Information
- State Administration of Foreign Experts Affairs (111-2-07)
- Ministry of Education of the People's Republic of China (111-2-07)
- National Natural Science Foundation of China (21778076)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 20 references indexed in Scilit:
- Azobenzene photocontrol of peptides and proteinsChemical Communications, 2016
- Heparin: Past, Present, and FuturePharmaceuticals, 2016
- Past, present, and future perspectives of heparins in clinical settings and the role of impaired renal functionInternational Journal of Cardiology, 2016
- Heparin and anticoagulationFrontiers in Bioscience-Landmark, 2016
- A Roadmap to Success in PhotopharmacologyAccounts of Chemical Research, 2015
- Controllable production of low molecular weight heparins by combinations of heparinase I/II/IIICarbohydrate Polymers, 2014
- Reversible Photocontrol of Biological Systems by the Incorporation of Molecular PhotoswitchesChemical Reviews, 2013
- Azobenzene photoswitches for biomoleculesChemical Society Reviews, 2011
- Heparin Mapping Using Heparin Lyases and the Generation of a Novel Low Molecular Weight HeparinJournal of Medicinal Chemistry, 2010
- Smart Biocatalysts: Design and Applications2003